Space food production brings cultivation and processing together

Metabolic differences between cancer and normal cells are accentuated by the selection pressure of therapy. Persisting cells enter a therapy-induced state of heightened, time-limited metabolic dependency. We argue that this interval can be exploited with metabolic modifiers to achieve persister cell death and improve cancer outcomes.